Archive for April 2025

The State of Antitrust M&A: 5 Takeaways from the 2025 ABA Antitrust Spring Meeting 

The 73rd annual “Spring Meeting” – globally the largest gathering of antitrust and competition specialists – just wrapped on April 4. Even having attended since the 42nd (yeah, I’m that “seasoned,” to use my preferred label), it was a standout. Here are 5 takeaways from my Antitrust M&A perspective: 1) It should go without saying, […]

Conducting effective regulatory diligence is foundational to life sciences transactions. At their core, life sciences companies and products are subject to a maze of laws and regulations.

Compliance with such laws and regulations is the cornerstone of a life sciences transaction and plays a vital role in the success of a transaction. However, conducting regulatory diligence often is a multifaceted exercise and involves immense amounts of information. It requires strategic considerations and sound judgments before, during, and after the transaction. Broadly speaking, […]